Viewing Study NCT05782127


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-16 @ 8:37 PM
Study NCT ID: NCT05782127
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-03-13
First Post: 2023-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module